68 Harley Street London, W1G 7HE · Main Office
Also at Cromwell & Syon Bishops Wood · Multiple Locations
0203 9838 001 Call for Appointments
jessica@oneheartclinic.com Rapid Response to Enquiries
Expert London Cardiologist for your Heart Health
A clear guide to the most commonly prescribed heart medications — what they do, how to take them, and what side effects to watch for. Click on any medication to expand the full details.
Each heart condition has a set of evidence-based medications that are used first. Find your condition below, then scroll down to expand the full details of each drug.
Each entry below shows the drug name, brand names, and what it is used for. Click the card to reveal full details: doses, timing, common side effects, unusual side effects, and important warnings.
| Drug | Starting dose | Maximum |
|---|---|---|
| Ramipril | 1.25–2.5mg once daily | 10mg once daily |
| Lisinopril | 2.5–5mg once daily | 40mg once daily |
| Perindopril | 2mg once daily | 8mg once daily |
When to take: Once daily at any consistent time. Evening dosing can reduce first-dose dizziness. Take with or without food.
Monitoring: Blood test for potassium and kidney function (creatinine/eGFR) 1–2 weeks after starting and after each dose increase. A small rise in creatinine (up to 30%) is expected and acceptable.
Important: Avoid ibuprofen and naproxen (NSAIDs) while on ACEi — the combination significantly increases kidney injury risk. Use paracetamol for pain instead.
| Drug | Starting dose | Maximum |
|---|---|---|
| Losartan | 25–50mg once daily | 100mg once daily |
| Candesartan | 4–8mg once daily | 32mg once daily |
| Valsartan | 40–80mg once daily | 320mg once daily |
When to take: Once daily at any consistent time, with or without food. Same monitoring as ACEi — potassium and kidney function check 1–2 weeks after starting.
No cough: ARBs block the angiotensin receptor but do not cause bradykinin accumulation — so they do not cause the dry cough seen with ACEi. They are the preferred alternative if cough is intolerable on an ACEi.
Do not combine: ACEi and ARB together — increases hyperkalaemia and kidney injury without added benefit (ONTARGET trial). Entresto (sacubitril/valsartan) replaces, not combines with, ACEi.
| Strength (sacubitril/valsartan) | Frequency |
|---|---|
| 24/26mg — starting dose | Twice daily |
| 49/51mg — intermediate | Twice daily |
| 97/103mg — target dose | Twice daily |
When to take: Twice daily, approximately 12 hours apart. Consistent timing is important. Take with or without food.
Switching from ACEi: A mandatory 36-hour washout after the last ACEi dose before starting Entresto. This prevents dangerously high bradykinin levels (angioedema risk).
Evidence: PARADIGM-HF trial (8,442 patients) — Entresto reduced cardiovascular death and heart failure hospitalisations by 20% compared with enalapril. It is now the preferred agent over ACEi/ARB in HFrEF.
Never combine with an ACEi — must be a replacement, not an addition. Minimum 36-hour gap after stopping ACEi before first Entresto dose.
| Drug | Starting dose | Maximum |
|---|---|---|
| Amlodipine | 5mg once daily | 10mg once daily |
| Felodipine | 2.5–5mg once daily | 10mg once daily |
| Nifedipine LA | 30mg once daily | 90mg once daily |
When to take: Once daily at any consistent time. Amlodipine has a very long half-life (~35 hours) — if you miss a dose, take it as soon as you remember unless it is nearly time for the next one. Food does not affect absorption.
Ankle swelling: The most common reason patients ask to stop amlodipine. It is caused by vasodilation (not fluid retention) — so diuretics don't help much, but adding an ACEi/ARB significantly reduces it. Reducing the dose also helps.
| Drug | Typical dose | Frequency |
|---|---|---|
| Diltiazem MR | 90–360mg | Once or twice daily |
| Verapamil SR | 120–480mg | Once or twice daily |
When to take: With food to reduce GI side effects. Diltiazem comes in many different brand formulations (Tildiem, Adizem, Dilzem, Viazem) — these are NOT interchangeable. Always take the specific brand prescribed and do not switch without your pharmacist's or cardiologist's advice.
Critical warning: Verapamil must NEVER be combined with a beta-blocker (e.g. bisoprolol, atenolol) without very careful cardiology supervision. The combination can cause complete heart block (the heart's electrical system stops) — a potentially fatal emergency.
| Strength (amlodipine/valsartan) | Frequency |
|---|---|
| 5mg/80mg, 5mg/160mg | Once daily |
| 10mg/160mg, 10mg/320mg | Once daily |
When to take: Once daily at any consistent time, with or without food. The fixed combination simplifies the regimen and improves adherence compared with taking two separate tablets.
ExForge HCT also exists — a triple combination adding hydrochlorothiazide (a diuretic). This is used in resistant hypertension requiring three drug classes simultaneously.
| Drug | Starting dose | Maximum |
|---|---|---|
| Bisoprolol | 1.25mg once daily | 10mg once daily |
| Carvedilol | 3.125mg twice daily | 25mg twice daily |
| Atenolol | 25mg once daily | 100mg once daily |
| Nebivolol | 1.25mg once daily | 10mg once daily |
When to take: Morning, once daily (bisoprolol, atenolol, nebivolol). Carvedilol twice daily with food — food slows absorption and reduces dizziness. Do not stop abruptly — reduce gradually over 2–4 weeks.
Never stop suddenly: Abrupt withdrawal causes rebound increase in heart rate and blood pressure and can trigger angina or heart attack in susceptible patients. Always reduce gradually under medical supervision.
| Drug | Dose | Frequency |
|---|---|---|
| Indapamide SR | 1.5mg | Once daily |
| Bendroflumethiazide | 2.5mg | Once daily |
| Hydrochlorothiazide | 12.5–25mg | Once daily |
When to take: Morning — avoids increased urination during the night. Take with or without food. Indapamide (particularly the SR/modified-release formulation) is preferred over older thiazides for its better cardiovascular outcome data.
Blood tests: Check sodium and potassium 4–6 weeks after starting. Low potassium (hypokalaemia) can cause dangerous heart rhythm abnormalities and may require potassium supplementation or adding a potassium-sparing diuretic.
| Drug | Typical dose | Frequency |
|---|---|---|
| Furosemide | 20–80mg (up to 500mg in severe HF) | Once or twice daily |
| Bumetanide | 0.5–5mg | Once daily |
When to take: Morning — or morning and early afternoon if twice daily. Never take in the evening or you will be awake urinating through the night. If you miss a morning dose, take it by lunchtime — skip it if later than that.
Self-monitoring: Weigh yourself every morning after using the toilet, before eating. If your weight rises by more than 2kg in 2 days — increase your furosemide by 20–40mg and contact your heart failure team. Sustained weight gain is a sign of fluid accumulating.
"Sick day rules": During vomiting, diarrhoea, or severe heat exposure — temporarily reduce or stop furosemide and increase fluid intake. Dehydration plus diuretics can cause acute kidney injury. Contact your team if unsure.
| Drug | HF dose | Frequency |
|---|---|---|
| Spironolactone | 25–50mg | Once daily |
| Eplerenone | 25–50mg | Once daily |
When to take: Once daily in the morning or evening — consistently with food. Eplerenone is more selective (fewer hormonal side effects) and is preferred in men who develop gynaecomastia on spironolactone.
Monitoring: Potassium and kidney function 1 week after starting and after each dose change. Potassium above 5.5 mmol/L — reduce dose. Above 6.0 mmol/L — stop and contact your team urgently.
Evidence: RALES trial — spironolactone 25mg reduced mortality by 30% in severe heart failure. EMPHASIS-HF — eplerenone reduced death and hospitalisation by 37% in mild heart failure.
| Drug | Dose | Frequency |
|---|---|---|
| Dapagliflozin | 10mg | Once daily (morning) |
| Empagliflozin | 10mg | Once daily (morning) |
When to take: Morning, with or without food. The morning is preferred because of mild diuretic effects — taking in the evening may cause overnight urination.
Sick day rules: Stop temporarily if you are acutely unwell, vomiting, fasting (e.g. before surgery), or severely dehydrated. Restart when eating and drinking normally. This reduces the risk of ketoacidosis.
Evidence: DAPA-HF and EMPEROR-Reduced — 25–26% reduction in CV death and heart failure worsening. Benefits apply whether or not the patient has diabetes. Now a standard part of all four recommended heart failure drug classes.
| Drug | Dose range | When to take |
|---|---|---|
| Atorvastatin | 10–80mg once daily | Any time |
| Rosuvastatin | 5–40mg once daily | Any time |
| Simvastatin | 10–40mg once daily | Evening |
| Pravastatin | 10–40mg once daily | Evening |
Timing: Atorvastatin and rosuvastatin have long half-lives — take at any consistent time. Simvastatin and pravastatin are shorter-acting and are more effective taken in the evening (the liver makes most cholesterol overnight). Post-heart attack: atorvastatin 80mg is started immediately regardless of baseline cholesterol.
Evidence: CTT meta-analysis of 26 trials (170,000 patients) — each 1 mmol/L reduction in LDL reduces major CV events by 22%. The effect is consistent, linear, and sustained only with daily adherence.
If you have muscle aches: Do not simply stop — check CK blood test first. Often switching to a different statin (e.g. rosuvastatin 5–10mg), reducing dose, or alternate-day dosing resolves symptoms while maintaining benefit.
Ezetimibe 10mg — once daily at any consistent time, with or without food. There is only one dose. It can be taken at the same time as a statin for convenience.
Ezetimibe works in the gut, blocking NPC1L1 — the transporter that absorbs dietary and biliary cholesterol. It reduces LDL by a further 20–25% on top of statin therapy.
IMPROVE-IT trial: Adding ezetimibe to simvastatin further reduced LDL and produced a modest but significant reduction in major CV events (6.4% relative risk reduction over 7 years). Every LDL reduction counts.
| Drug | Dose | Frequency |
|---|---|---|
| Evolocumab | 140mg SC | Every 2 weeks (or 420mg monthly) |
| Alirocumab | 75–150mg SC | Every 2 weeks |
| Inclisiran | 284mg SC | Day 1, Month 3, then every 6 months (given in clinic) |
Self-injection: Evolocumab and alirocumab come as auto-injectors for home use (similar to insulin pens). Inclisiran is administered by a healthcare professional in clinic — making it the preferred option for patients who struggle with adherence.
FOURIER trial (evolocumab): 59% LDL reduction; 15% reduction in major CV events. NHS-funded for familial hypercholesterolaemia and secondary prevention patients above LDL thresholds despite maximum tolerated statin therapy.
75mg once daily — the standard UK secondary prevention dose. (300mg loading dose is given in hospital at time of heart attack or stroke.)
When to take: With or after food — significantly reduces gastric irritation. Take at any consistent time. Enteric-coated (EC) aspirin may reduce GI side effects further, though evidence is mixed.
PPI co-prescription: If you are over 65, have a history of GI problems, or are on dual antiplatelet therapy — a proton pump inhibitor (omeprazole 20mg once daily) should be prescribed alongside aspirin to reduce stomach bleeding risk.
Not for primary prevention: ARRIVE and ASPREE trials showed no net benefit (and possible harm) from aspirin in people without established cardiovascular disease. Aspirin for the heart is only recommended after a heart attack, stent, or ischaemic stroke.
| Drug | Dose | Frequency |
|---|---|---|
| Clopidogrel | 75mg | Once daily |
| Ticagrelor | 90mg (year 1), 60mg (year 2+) | Twice daily |
| Prasugrel | 10mg (5mg if >75 or <60kg) | Once daily |
When to take: Clopidogrel and prasugrel — once daily with or without food. Ticagrelor must be taken twice daily, 12 hours apart — missing doses significantly impairs antiplatelet effect.
Duration after stenting: 12 months for heart attack (ACS); 1–6 months for elective stenting depending on bleeding vs thrombosis risk. Your cardiologist will specify your duration.
Critical — do not stop without contacting your cardiologist. Stopping antiplatelet therapy early after stenting causes stent thrombosis — the stent suddenly clots, causing a heart attack that is often fatal. Even a brief pause (e.g. before dental work) requires prior cardiologist advice.
| Drug | AF dose | Frequency |
|---|---|---|
| Apixaban | 5mg (2.5mg if ≥2 criteria*) | Twice daily |
| Rivaroxaban | 20mg with evening meal | Once daily |
| Dabigatran | 150mg (110mg if >80 or on verapamil) | Twice daily |
| Edoxaban | 60mg (30mg if CrCl 15–50 or ≤60kg) | Once daily |
*Apixaban dose reduction criteria: age ≥80, weight ≤60kg, or creatinine ≥133 — reduce if ≥2 of these apply.
Rivaroxaban: Must be taken with the main evening meal — food increases absorption by 40%. This is critically important; taking it fasted greatly reduces blood levels.
Dabigatran: Keep in the original blister pack — the capsule is moisture-sensitive and degrades rapidly if stored in a dosette box.
Reversal agents available: Idarucizumab (Praxbind) reverses dabigatran; andexanet alfa (Ondexxya) reverses apixaban and rivaroxaban. All major UK hospitals hold these. NOACs cannot be monitored with standard INR testing.
Dose is highly individual — ranges from 0.5mg to 15mg daily, adjusted based on INR (International Normalised Ratio) blood test results. There is no standard dose.
INR targets: 2.0–3.0 for AF, DVT, PE, and most indications. 2.5–3.5 for mechanical mitral valve or recurrent clot on standard warfarin.
When to take: Evening — this allows a morning INR blood test result to inform your dose adjustment the same day without a gap in anticoagulation.
Vitamin K and diet: Warfarin works by blocking vitamin K. Consistency matters more than avoidance — do not suddenly increase or decrease leafy greens (kale, spinach, broccoli, sprouts). Eat them regularly and consistently.
Interactions: Warfarin interacts with almost everything — antibiotics (especially clarithromycin, metronidazole, ciprofloxacin), NSAIDs, antifungals, amiodarone, St John's Wort, cranberry juice, and many more. Always tell your anticoagulation team before starting any new medication, supplement, or herbal product.
| Phase | Dose | Duration |
|---|---|---|
| Loading (hospital or GP) | 200mg three times daily | 4 weeks |
| Reducing | 200mg twice daily | 4 weeks |
| Maintenance | 200mg once daily | Ongoing |
When to take: Once daily maintenance dose — with food to reduce nausea. Very long half-life (40–55 days) — amiodarone takes weeks to reach full effect and its effects persist for months after stopping.
Annual monitoring: Thyroid function (TFT), liver function (LFT), chest X-ray, and ophthalmology eye check — every 12 months minimum.
| Use | Dose | Frequency |
|---|---|---|
| Maintenance | 50–150mg | Twice daily |
| "Pill-in-pocket" (paroxysmal AF) | 200–300mg single dose | As needed for AF episodes |
Timing: Twice daily doses, 12 hours apart, with or without food. The "pill-in-pocket" approach — taking a single dose at the onset of AF to restore normal rhythm — is only suitable for selected patients with structurally normal hearts and must be initiated under cardiology supervision.
62.5–250 micrograms once daily — lower doses in the elderly and in kidney impairment (digoxin is renally cleared). The target serum level is now recommended at the lower end of the therapeutic range: 0.5–0.9 ng/mL.
When to take: Once daily — consistent timing. Blood level is checked at least 6 hours after the last dose (not immediately before the next dose). Your team will specify when to take the blood test.
Narrow therapeutic window: The difference between an effective dose and a toxic dose is small. Kidney deterioration, dehydration, low potassium (furosemide), and drug interactions all affect digoxin levels. Regular blood tests and awareness of toxicity signs are essential.
| Dose | Frequency |
|---|---|
| 2.5mg, 5mg, or 7.5mg | Twice daily with morning and evening meals |
Important: Ivabradine only slows heart rate in sinus rhythm. It has no rate-slowing effect during atrial fibrillation. If you notice your heart rate is not falling on the drug, contact your cardiologist — it may mean you are in AF.
Ivabradine selectively slows the heart rate without affecting blood pressure or cardiac contractility — this makes it particularly useful in patients who cannot tolerate the blood pressure-lowering effects of beta-blockers.
1 spray (400 micrograms) under the tongue — sit or lie down first. Do not inhale or swallow. Allow the spray to absorb under the tongue.
If pain not relieved after 5 minutes — take a second spray. If pain persists 5 minutes after the second spray (10 minutes total) — call 999 immediately. Do not take a third spray and wait. This may be a heart attack.
GTN may also be taken before exertion — spray 1–2 minutes before an activity known to trigger angina (e.g. walking uphill, stairs). The effect lasts 20–30 minutes.
Storage: Keep at room temperature, away from heat and sunlight. GTN degrades with time — check expiry date. Prime the spray before first use (press the nozzle 5 times). Always carry it with you.
| Formulation | Dose | Timing |
|---|---|---|
| Standard-release | 10–20mg | Morning and lunchtime (NOT evening) |
| Modified-release (MR/SR) | 25–120mg | Once daily, morning only |
Why timing is critical: Nitrate tolerance — the loss of drug effect — develops when nitrate levels in the blood are continuously high. An 8–12 hour nitrate-free period overnight is essential to prevent tolerance. Standard-release ISMN must be taken morning and lunchtime (not evening or night). Modified-release taken once in the morning achieves the same nitrate-free overnight gap.
Same PDE5 interaction as GTN spray — do not take sildenafil (Viagra) within 24 hours or tadalafil (Cialis) within 48 hours of any nitrate preparation. Severe hypotension risk.
| Dose | Frequency |
|---|---|
| 375mg initially → 500mg → 750mg | Twice daily |
When to take: Twice daily, 12 hours apart. Swallow whole — do not crush or chew (modified-release tablet). Take with or without food.
Advantage: Ranolazine does not lower heart rate or blood pressure — it can be added to maximally tolerated doses of beta-blockers, nitrates, and amlodipine without worsening low BP or bradycardia. This makes it particularly useful as an add-on.
Mechanism: Reduces the "late" sodium current in ischaemic heart muscle cells, reducing calcium overload and thereby reducing angina. Unique mechanism compared to all other antianginals.
Avoid grapefruit juice — grapefruit inhibits CYP3A4, significantly increasing ranolazine blood levels and side effect risk. Limit or avoid grapefruit and grapefruit juice while on ranolazine.
Abrupt withdrawal of beta-blockers can trigger rebound angina or heart attack. Stopping antiplatelets after stenting risks stent thrombosis. Stopping anticoagulation in AF risks stroke. Always contact your cardiologist before stopping any cardiac drug.
Consistency stabilises blood levels. This is especially important for twice-daily drugs (ticagrelor, Entresto, flecainide, apixaban) where uneven spacing reduces protection. Set a phone alarm if needed.
This includes your GP, hospital doctors, dentists, surgeons, physiotherapists, and pharmacists. Cardiac medications interact with anaesthetics, antibiotics, pain relief, and dental drugs. A complete medication list — including doses — should be in your wallet or on your phone.
NSAIDs increase blood pressure, reduce the effectiveness of ACEi/ARBs, increase bleeding risk on antiplatelets and anticoagulants, and can trigger acute kidney injury when combined with diuretics and ACEi ("triple whammy"). Use paracetamol for pain instead.
Several cardiac drugs require regular monitoring: ACEi/ARBs/Entresto (potassium, creatinine), spironolactone (potassium), amiodarone (TFTs, LFTs), digoxin (drug levels), and warfarin (INR). Missing monitoring tests allows problems to develop silently.
During vomiting, diarrhoea, or severe dehydration — temporarily stop ACEi/ARBs, diuretics, and SGLT2 inhibitors until you are eating and drinking normally again. Continuing these when dehydrated can cause acute kidney injury. Contact your team if unsure or if illness lasts more than 24–48 hours.
In any emergency — cardiac arrest, accident, hospital admission — paramedics and doctors need to know what you take. Keep an up-to-date list (drug names, doses, frequencies) in your wallet, on your phone, or on your fridge. The NHS app now stores this digitally.
Many side effects — fatigue on beta-blockers, headache on nitrates, ankle swelling on amlodipine — are most pronounced in the first 2–4 weeks and improve substantially as the body adapts. Try to persist through this period before assuming you cannot tolerate a drug. Contact your team if severe.
Several supplements interact dangerously with cardiac medications: nattokinase with anticoagulants, St John's Wort with warfarin/digoxin/amiodarone, high-dose fish oil with antiplatelets. Tell your cardiologist about everything you take — prescription, supplement, herbal, or over-the-counter.
It is natural to feel anxious reading a list of potential side effects. Most people take cardiac medications for years or decades with minimal problems. The cardiovascular events prevented by these drugs — heart attacks, strokes, sudden death — are far more serious than almost any medication side effect. If in doubt, ask your cardiologist directly.
These condition guides include more detail on the specific medications used for each diagnosis.
A consultation with Dr Nijjer includes a full review of your medications, side effects, and whether any adjustments would benefit your heart health.
Book a ConsultationMedical disclaimer. This page provides general educational information about cardiac medications and does not constitute personal medical advice. Doses, indications, and side effects described are typical but vary between individuals. Do not start, stop, or change any medication without consulting your cardiologist or GP. In an emergency — chest pain, collapse, severe bleeding, or sudden breathlessness — call 999 immediately.